China Shineway Pharmaceutical Group Limited Financial Overview
China Shineway Pharmaceutical Group Limited's market cap is currently HK$6.57B. The company's EPS TTM is HK$0.8854917084; its P/E ratio is 7.37; and it has a dividend yield of 5.80%. China Shineway Pharmaceutical Group Limited is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
